Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis.

Chen YG, Wang Q, Lin SL, Chang CD, Chuang J, Ying SY.

Exp Biol Med (Maywood). 2006 May;231(5):534-44. Review. Erratum in: Exp Biol Med (Maywood). 2006 Sep;231(8):1448. Chung, Jody [corrected to Chuang, Jody].

PMID:
16636301
2.

Negative regulation of activin signal transduction.

Choi SC, Han JK.

Vitam Horm. 2011;85:79-104. doi: 10.1016/B978-0-12-385961-7.00005-6. Review.

PMID:
21353877
3.

Antagonists of activin signaling: mechanisms and potential biological applications.

Harrison CA, Gray PC, Vale WW, Robertson DM.

Trends Endocrinol Metab. 2005 Mar;16(2):73-8. Review.

PMID:
15734148
4.

Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.

Tsuchida K, Nakatani M, Uezumi A, Murakami T, Cui X.

Endocr J. 2008 Mar;55(1):11-21. Epub 2007 Sep 14. Review.

5.

Activin receptor signaling.

Abe Y, Minegishi T, Leung PC.

Growth Factors. 2004 Jun;22(2):105-10. Review.

PMID:
15253386
6.

The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells.

Mabuchi Y, Yamoto M, Minami S, Umesaki N.

Oncol Rep. 2006 Aug;16(2):373-9.

PMID:
16820918
8.

Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.

Panopoulou E, Murphy C, Rasmussen H, Bagli E, Rofstad EK, Fotsis T.

Cancer Res. 2005 Mar 1;65(5):1877-86.

9.

Inhibins are the major activin ligands expressed during early thymocyte development.

Licona P, Chimal-Monroy J, Soldevila G.

Dev Dyn. 2006 Apr;235(4):1124-32.

10.
11.

Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation.

Gilchrist RB, Ritter LJ, Myllymaa S, Kaivo-Oja N, Dragovic RA, Hickey TE, Ritvos O, Mottershead DG.

J Cell Sci. 2006 Sep 15;119(Pt 18):3811-21. Epub 2006 Aug 22.

12.

Oocyte-secreted factor activation of SMAD 2/3 signaling enables initiation of mouse cumulus cell expansion.

Dragovic RA, Ritter LJ, Schulz SJ, Amato F, Thompson JG, Armstrong DT, Gilchrist RB.

Biol Reprod. 2007 May;76(5):848-57. Epub 2006 Dec 27.

PMID:
17192514
13.

Activins and inhibins and their signaling.

Vale W, Wiater E, Gray P, Harrison C, Bilezikjian L, Choe S.

Ann N Y Acad Sci. 2004 Dec;1038:142-7.

PMID:
15838109
14.

Cripto forms a complex with activin and type II activin receptors and can block activin signaling.

Gray PC, Harrison CA, Vale W.

Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5193-8. Epub 2003 Apr 7.

15.
16.

Regulation of cell proliferation, apoptosis, and carcinogenesis by activin.

Chen YG, Lui HM, Lin SL, Lee JM, Ying SY.

Exp Biol Med (Maywood). 2002 Feb;227(2):75-87. Review.

PMID:
11815670
17.

Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.

Matsuo SE, Leoni SG, Colquhoun A, Kimura ET.

J Endocrinol. 2006 Jul;190(1):141-50.

18.

Activin signaling as an emerging target for therapeutic interventions.

Tsuchida K, Nakatani M, Hitachi K, Uezumi A, Sunada Y, Ageta H, Inokuchi K.

Cell Commun Signal. 2009 Jun 18;7:15. doi: 10.1186/1478-811X-7-15.

19.

Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth.

Razanajaona D, Joguet S, Ay AS, Treilleux I, Goddard-Léon S, Bartholin L, Rimokh R.

Cancer Res. 2007 Aug 1;67(15):7223-9.

20.

Supplemental Content

Support Center